
Forthcoming launch of CARA Publisher
Generis announces forthcoming launch of CARA Publisher: One Platform from Authoring to Submission and Archival Built natively on CARA, CARA Publisher publishes submissions in place

Generis announces forthcoming launch of CARA Publisher: One Platform from Authoring to Submission and Archival Built natively on CARA, CARA Publisher publishes submissions in place
We are proud to congratulate our partner EXTEDO on the signing of a new agreement with Digital Access to Finance (DAF), under the witness of

Immunic Therapeutics Selects CARA Life Sciences Platform to Streamline Regulatory Operations and Accelerate Submissions CARA Life Sciences Platform Adoption Continues to Grow with Biotech Organisation

Loba biotech GmbH, a wholly owned GMP manufacturing subsidiary of pharmaand GmbH (pharma&), has chosen Generis’ CARA Life Sciences Platform to launch its digital Quality

AI-powered CARA Platform and new Starter Pack Model fuel rapid expansion across regulated sectors LONDON, UK – Generis, creator of the CARA Platform and CARA

Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences